VIA

Virtus Investment Advisers Portfolio holdings

AUM $296M
1-Year Return 31.42%
This Quarter Return
+9.26%
1 Year Return
+31.42%
3 Year Return
+126.24%
5 Year Return
–
10 Year Return
–
AUM
$296M
AUM Growth
-$72M
Cap. Flow
-$86.7M
Cap. Flow %
-29.31%
Top 10 Hldgs %
6.88%
Holding
512
New
39
Increased
197
Reduced
202
Closed
70

Top Buys

1
CEG icon
Constellation Energy
CEG
$2.01M
2
DASH icon
DoorDash
DASH
$1.82M
3
VEEV icon
Veeva Systems
VEEV
$1.75M
4
CSCO icon
Cisco
CSCO
$1.7M
5
STT icon
State Street
STT
$1.69M

Top Sells

1
VABS icon
Virtus Newfleet ABS/MBS ETF
VABS
$32.2M
2
VSHY icon
Virtus Newfleet Short Duration High Yield Bond ETF
VSHY
$24.6M
3
SEIX icon
Virtus SEIX Senior Loan ETF
SEIX
$19M
4
SMC
Summit Midstream Corporation
SMC
$3.67M
5
JNK icon
SPDR Bloomberg High Yield Bond ETF
JNK
$2.09M

Sector Composition

1 Financials 33.24%
2 Healthcare 17.43%
3 Technology 12.41%
4 Industrials 9.1%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
GLAD icon
176
Gladstone Capital
GLAD
$585M
$597K 0.2%
22,133
-3,137
-12% -$84.6K
MPV
177
Barings Participation Investors
MPV
$208M
$572K 0.19%
28,448
-10,501
-27% -$211K
BCIC
178
BCP Investment Corporation Common Stock
BCIC
$160M
$546K 0.18%
43,619
+5,775
+15% +$72.3K
CRSP icon
179
CRISPR Therapeutics
CRSP
$4.8B
$524K 0.18%
10,765
+2,860
+36% +$139K
MRCC icon
180
Monroe Capital Corp
MRCC
$164M
$523K 0.18%
82,292
+6,693
+9% +$42.6K
OFS icon
181
OFS Capital
OFS
$116M
$523K 0.18%
61,914
-16,664
-21% -$141K
MAIN icon
182
Main Street Capital
MAIN
$5.96B
$518K 0.18%
8,758
-624
-7% -$36.9K
WHF icon
183
WhiteHorse Finance
WHF
$202M
$508K 0.17%
58,256
-74,765
-56% -$652K
IONS icon
184
Ionis Pharmaceuticals
IONS
$9.46B
$493K 0.17%
12,476
+2,775
+29% +$110K
OXSQ icon
185
Oxford Square Capital
OXSQ
$172M
$492K 0.17%
220,488
-11,097
-5% -$24.7K
BBIO icon
186
BridgeBio Pharma
BBIO
$9.91B
$484K 0.16%
11,208
-1,770
-14% -$76.4K
ALNY icon
187
Alnylam Pharmaceuticals
ALNY
$59.4B
$476K 0.16%
1,459
-8
-0.5% -$2.61K
EXEL icon
188
Exelixis
EXEL
$10.1B
$469K 0.16%
10,637
+428
+4% +$18.9K
ARDX icon
189
Ardelyx
ARDX
$1.58B
$468K 0.16%
119,461
+50,946
+74% +$200K
TBPH icon
190
Theravance Biopharma
TBPH
$708M
$462K 0.16%
41,884
+5,505
+15% +$60.7K
INSM icon
191
Insmed
INSM
$30.1B
$462K 0.16%
4,587
-399
-8% -$40.2K
MIRM icon
192
Mirum Pharmaceuticals
MIRM
$3.73B
$461K 0.16%
9,066
+574
+7% +$29.2K
AUPH icon
193
Aurinia Pharmaceuticals
AUPH
$1.65B
$457K 0.15%
53,997
+16,946
+46% +$144K
MDGL icon
194
Madrigal Pharmaceuticals
MDGL
$9.61B
$452K 0.15%
1,495
+307
+26% +$92.9K
BNTX icon
195
BioNTech
BNTX
$24.9B
$451K 0.15%
4,236
+1,260
+42% +$134K
ASND icon
196
Ascendis Pharma
ASND
$12B
$449K 0.15%
2,600
-147
-5% -$25.4K
MRNA icon
197
Moderna
MRNA
$9.45B
$448K 0.15%
16,248
+7,863
+94% +$217K
REGN icon
198
Regeneron Pharmaceuticals
REGN
$60.1B
$447K 0.15%
852
+366
+75% +$192K
NBIX icon
199
Neurocrine Biosciences
NBIX
$13.9B
$447K 0.15%
3,555
+722
+25% +$90.7K
UTHR icon
200
United Therapeutics
UTHR
$17.2B
$446K 0.15%
1,553
+559
+56% +$161K
6 7
8
9 10